Results 241 to 250 of about 42,337 (292)

EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes. [PDF]

Exp Hematol Oncol
Zhang Q, Luo Y, Ye L, Wang Y, Wang L, Yang W, Lang W, Zhu S, Jiang L, Jin W, Mei C, Zhou X, Ren Y, Ma L, Xu G, Bowattage BGLVB, Tong H, Sun J.   +17 more
europepmc   +1 more source

Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm. [PDF]

Blood Neoplasia
Xie Z, Al Ali N, Zhang L, Papenhausen P, Volpe VO, Chan O, Kuykendall A, Yun S, Walker A, Sweet K, Lancet JE, Padron E, Sallman DA, Komrokji RS.   +13 more
europepmc   +1 more source

Prognostic Role of Adaptive Immune Microenvironment in Patients with High-Risk Myelodysplastic Syndromes Treated with 5-Azacytidine. [PDF]

Cancers (Basel)
Tsakiraki Z, Spathis A, Bouchla A, Pouliakis A, Vryttia P, Panayiotides IG, Pappa V, Papageorgiou SG, Foukas PG.   +8 more
europepmc   +1 more source

Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes. [PDF]

Nat Commun
Rodriguez-Sevilla JJ, Ganan-Gomez I, Kumar B, Thongon N, Ma F, Chien KS, Kim YJ, Yang H, Loghavi S, Tan R, Adema V, Li Z, Tanaka T, Uryu H, Kanagal-Shamanna R, Al-Atrash G, Bejar R, Banerjee PP, Lynn Cha S, Montalban-Bravo G, Dougherty M, Fernandez Laurita MC, Wheeler N, Jia B, Papapetrou EP, Izzo F, Dueñas DE, McAllen S, Gu Y, Todisco G, Ficara F, Della Porta MG, Jain A, Takahashi K, Clise-Dwyer K, Halene S, Bertilaccio MTS, Garcia-Manero G, Daher M, Colla S.   +39 more
europepmc   +1 more source

Successful treatment of multi-hit TP53-mutated myelodysplastic syndromes with erythroid predominance using allogeneic stem cell transplantation and ruxolitinib. [PDF]

Ann Hematol
Oshima S, Kanda J, Takeda J, Sakamoto T, Mizumoto C, Yamashita K, Nannya Y, Ogawa S, Takaori-Kondo A.   +8 more
europepmc   +1 more source

Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis. [PDF]

Br J Haematol
Sun T, Singh S, Wang HC, Lee J, Dolatshad H, Cheong PL, Higgs DR, Boultwood J, Pellagatti A.   +8 more
europepmc   +1 more source

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Blood
Bernard E, Hasserjian RP, Greenberg PL, Arango Ossa JE, Creignou M, Tuechler H, Gutierrez-Abril J, Domenico D, Medina-Martinez JS, Levine M, Liosis K, Farnoud N, Sirenko M, Jädersten M, Germing U, Sanz G, van de Loosdrecht AA, Nannya Y, Kosmider O, Follo MY, Thol F, Zamora L, Pinheiro RF, Pellagatti A, Elias HK, Haase D, Ganster C, Ades L, Tobiasson M, Palomo L, Della Porta MG, Fenaux P, Belickova M, Savona MR, Klimek VM, Santos FPS, Boultwood J, Kotsianidis I, Santini V, Solé F, Platzbecker U, Heuser M, Valent P, Finelli C, Voso MT, Shih LY, Fontenay M, Jansen JH, Cervera J, Gattermann N, Ebert BL, Bejar R, Malcovati L, Ogawa S, Cazzola M, Hellström-Lindberg E, Papaemmanuil E.   +56 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myelodysplastic Syndromes

Annals of the New York Academy of Sciences, 2004
Abstract: Efforts made during the last few years have helped unravel the complex pathogenesis of the myelodysplastic syndromes (MDS). A large number of studies, made possible by the introduction of newer technologies, have led to major progress in understanding the heterogeneous genetic and biological abnormalities contributing to the development and ...
CILLONI, Daniela, MESSA F, CARTURAN S, ARRUGA F, DEFILIPPI I, MESSA E, GOTTARDI E, SAGLIO, Giuseppe   +7 more
  +8 more sources

Myelodysplastic syndromes

Hematology and Cell Therapy, 1996
The authors review the epidemiological biological, diagnostic, prognostic and therapeutic aspects of myelodysplastic syndromes.
J F, San Miguel, G F, Sanz, T, Vallespí, M C, del Cañizo, M A, Sanz   +4 more
  +9 more sources